Neuroblastoma - 88 Studies Found Recruiting : Esthesioneuroblastoma: Outcomes After Treatment : Esthesioneuroblastoma, Olfactory : 2015-09-13 Completed : Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer : Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Basal Cell Carcinoma of the : 2011-10-20 : Drug: everolimus Given PO Completed : Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer : Anaplastic Thyroid Cancer Insular Thyroid Cancer Metastati : 2003-09-10 : Drug: gefitinib Given orally Other Names: Completed : Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer : Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma A : 2007-06-25 : Drug: bevacizumab Given IV Active, not recruiting : Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer : Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Basal Cell Carcinoma of the : 2007-05-03 : Drug: HPPH Given IV Completed : Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer : Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Adenoi : 2001-09-13 : Drug: hydroxyurea Given orally Completed : Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer : Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Adenoi : 2005-01-07 : Drug: erlotinib hydrochloride Completed : Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors : Male Breast Cancer Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Drug: alvespimycin hydrochloride Completed : Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer : Adenocarcinoma of the Colon Adenocarcinoma of the Rectum A : 2006-11-08 : Drug: cetuximab Given IV Completed : 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) : Advanced Adult Primary Liver Cancer Carcinoma of the Appendix Drug: 7-hydroxystaurosporine G Next >>>